Interesting data point, thanks. Argentina should be able to show data for this as well, though, I wonder why there haven't been equivalent studies here. I see that people who got Sinopharm are being offered a second dose fairly quickly, two of my colleagues (in their 40s) have both doses already, one lives in CABA, the other in PBA.21 July 2020 at 12:17pm
Sinopharm vaccine induces weaker antibody responses against Delta variant. A study presented today concludes that the people who received it had a reduction of 1.38 times compared to the original virus.Un estudio presentado hoy concluye que las personas que la recibieron tuvieron una reducción de 1,38 veces con respecto al virus originalwww.lanacion.com.ar
Argentina is one of the countries that includes it in its vaccination campaign.